{
    "Trade/Device Name(s)": [
        "Liquichek Diabetes Control"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K052838",
    "Predicate Device Reference 510(k) Number(s)": [
        "K862186"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGM"
    ],
    "Summary Letter Date": "November 9, 2005",
    "Summary Letter Received Date": "October 7, 2005",
    "Submission Date": "October 5, 2005",
    "Regulation Number(s)": [
        "21 CFR 864.8625"
    ],
    "Regulation Name(s)": [
        "Hematology Quality Control Mixture"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin A1C",
        "Total Hemoglobin"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad Laboratories Liquichek Diabetes Control, a whole blood-based hematology quality control material for laboratory assay precision monitoring",
    "Indications for Use Summary": "Liquichek Diabetes Control is intended for use as an assayed quality control material to monitor the precision of laboratory testing procedures for the analytes listed in the package insert.",
    "fda_folder": "Hematology"
}